ERAXIS

Main information

  • Trade name:
  • ERAXIS 100 MG INJ
  • Dosage:
  • 100MG
  • Pharmaceutical form:
  • INJ
  • Composition:
  • 100 MG
  • Medicine domain:
  • Humans
  • Medicine type:
  • Allopathic drug

Documents

Localization

  • Available in:
  • ERAXIS 100 MG INJ
    India
  • Language:
  • English

Other information

Status

  • Source:
  • Central Drugs Standard Control Organization
  • Last update:
  • 09-08-2016

There are no safety alerts related to this product.

12-1-2018

ERAXIS (Anidulafungin) Injection, Powder, Lyophilized, For Solution [Roerig]

ERAXIS (Anidulafungin) Injection, Powder, Lyophilized, For Solution [Roerig]

Updated Date: Jan 12, 2018 EST

US - DailyMed

30-5-2017

Ecalta (Pfizer Limited)

Ecalta (Pfizer Limited)

Ecalta (Active substance: anidulafungin) - Centralised - Yearly update - Commission Decision (2017)3754 of Tue, 30 May 2017

Europe -DG Health and Food Safety